AREG and type 1 diabetes mellitus: The potential role for this pathway in T1D is consistent with observed reduced levels of amphiregulin in recently diagnosed patients10, and decreased levels of another EGFR ligand, epiregulin, in individuals at a high risk of developing T1D11.